Ambulatory Care Drives Tenet Healthcare Corporation (THC)'s Strong Earnings Momentum

We recently compiled a list of the 10 Cheap Stocks With Strong Buy Ratings on Wall Street. Tenet Healthcare Corporation (THC) is among the other cheap stocks.

On December 18, TheFly reported that Morgan Stanley reiterated its Overweight rating on THC and maintained a $247 price target, citing confidence in the company’s operational execution and strong positioning within healthcare services. Earlier, on December 2, Guggenheim maintained its Buy rating and raised its price target to $257, reflecting similar optimism.

Tenet Healthcare Corporation (NYSE:THC)’s positive momentum is supported by its Q3 2025 results, which showed adjusted EBITDA of $1.099 billion, a year‑over‑year increase of more than 12%. Growth in ambulatory care earnings highlighted rising outpatient procedures and a shift toward higher-margin services. The company also raised its 2025 adjusted EBITDA guidance to $4.47 billion–$4.57 billion, signaling continued margin expansion and disciplined cost management.

Analysts view Tenet’s strong performance in ambulatory care and improving profitability as outweighing typical sector risks, such as reimbursement pressures and cyclicality in elective procedures.

Tenet Healthcare Corporation (NYSE:THC) is a diversified U.S. healthcare services company headquartered in Dallas, Texas. It operates an extensive network of acute care and specialty hospitals, ambulatory surgery centers, outpatient facilities, and physician practices across the United States.

While we acknowledge the potential of THC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy NOW 

Disclosure: None.